Indirect comparison of elranatamab in MagnetisMM-3 versus real-world treatment regimens VJHemOnc – Video Journal of Hematology & HemOnc 1:35 5 months ago 61 Далее Скачать
Evaluating the safety and efficacy of elranatamab in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:17 1 year ago 266 Далее Скачать
Elranatamab: Extended Follow-up & Biweekly Admin for RRMM | MagnetisMM-3 Study | ASCO 2023 International Myeloma Foundation 6:54 1 year ago 705 Далее Скачать
Elranatamab for R/R myeloma: long-term updates from MagnetisMM-3 & real-world safety of this agent VJHemOnc – Video Journal of Hematology & HemOnc 6:07 5 months ago 570 Далее Скачать
MagnetisMM-3: elranatamab in R/R multiple myeloma naive to BCMA-directed therapy VJHemOnc – Video Journal of Hematology & HemOnc 6:07 1 year ago 448 Далее Скачать
Patient-reported outcomes with the use of elranatamab in the MagnetisMM-3 trial VJHemOnc – Video Journal of Hematology & HemOnc 3:27 1 year ago 348 Далее Скачать
MagnetisMM-3: correcting hypogammaglobulinemia & using Ig replacement therapy to reduce infections VJHemOnc – Video Journal of Hematology & HemOnc 3:47 1 year ago 276 Далее Скачать
Impact of prior BCMA-directed therapy on the efficacy of elranatamab in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:52 1 year ago 111 Далее Скачать
MagnetisMM-3 extended follow up results: elranatamab monotherapy in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 5:49 1 year ago 370 Далее Скачать
MagnetisMM-3: elranatamab for myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:16 3 years ago 499 Далее Скачать
MagnetisMM-3: elranatamab in relapsed/refractory multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 10:39 2 years ago 550 Далее Скачать
Ongoing studies of elranatamab in frail patients & with DaraPomDex: MagnetisMM-3 & MagnetisMM-5 VJHemOnc – Video Journal of Hematology & HemOnc 6:14 1 year ago 165 Далее Скачать
Dr Mohty on the Real-World Efficacy of Elranatamab in R/R Multiple Myeloma OncLive 2:00 5 months ago 95 Далее Скачать
Efficacy and Safety of Elranatamab in Pts with Relapsed/Refractory Multiple Myeloma: MagnetisMM-3 International Myeloma Foundation 9:14 1 year ago 769 Далее Скачать
Initial Safety Results for Phase 2 MagnetisMM-3 Trial Presented at ASCO 2022 International Myeloma Foundation 8:33 2 years ago 779 Далее Скачать
Safety and efficacy of elranatamab in RRMM & prior BCMA therapies: Analysis from MagnetisMM studies International Myeloma Foundation 7:04 1 year ago 237 Далее Скачать
Elranatamab in Combination with Daratumumab for Pts with RRMM: Phase 3 MagnetisMM-5 International Myeloma Foundation 9:07 1 year ago 546 Далее Скачать
Exciting treatment combinations emerging in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:58 2 years ago 133 Далее Скачать
Dirençli ve Nüks Miyelom - Merve Pamukçuoğlu Lösemi Lenfoma Miyelom Derneği 25:20 1 year ago 107 Далее Скачать
MagnetisMM-3: update on efficacy and safety of less frequent dosing of elranatamab in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:14 1 day ago 40 Далее Скачать
